Director, Pharmacy Supply Chain Resilience

ASHP

21d•$140,000 - $165,000•Remote

About The Position

ASHP is an award-winning Association with a great mission. ASHP is the collective voice of pharmacists, representing more than 60,000 members. ASHP has recently won awards for being a Top Workplace for our work culture which fosters learning, collaboration, and for being inclusive. The Director, Pharmacy Supply Chain Resilience will be responsible for leading and supporting activities related to FDA grant project 1R01FD008718-01: Identifying drugs vulnerable to shortage or fraudulent activity and proactively addressing barriers to outsourcing facility production of drugs to prevent shortages. At ASHP, we consider skills, experience, and organizational needs in our compensation approach. The salary range for this position is $140,000-165,000 and ASHP offers a comprehensive benefits plan. Click ASHP Benefits to learn more about our benefits. This position is eligible to be remote but the individual must work from one of the following states so we can follow appropriate tax laws: AZ, CA, CO, DC, FL, GA, IL, IN, IA, KY, MA, MD, MI, MN, MS, NC, NJ, NY, OH, OR, PA, RI, SC, SD, TX, VA, WI, WV. This position is a grant-funded position and employment is contingent upon grant funding with a projected end date of August 31, 2028. Note: this position is not eligible for Visa sponsorship.

Requirements

Requires a Doctor of Pharmacy degree or minimum of a degree and extensive clinical or operational experience required.
Exceptional oral and written communication skills required; previous publishing and presenting experienced preferred.
Demonstrated analytical and problem-solving skills
Ability to build and maintain positive professional relationships and networks.

Nice To Haves

Completion of an ASHP-accredited post-graduate year of residency, or equivalent experience preferred.
Five years or more of prior related work experience and is recognized as a subject matter expert in their field/discipline preferred.

Responsibilities

Works with Grants Manager and Principal Investigator (PI) to design, execute, and monitor programs and activities related to FDA grant project 1R01FD008718-01: Identifying drugs vulnerable to shortage or fraudulent activity and proactively addressing barriers to outsourcing facility production of drugs to prevent shortages.
Prepares for, leads, and summarizes expert panel meetings related to FDA grant project.
Leads expert panel development of prioritized essential medicines list vulnerable to shortage or supply disruption.
Leads expert panel identification of prioritized essential medicines ideal for outsourcing facility formulation development.
Leads process of designing and implementing request-for-proposal (RFP) process related to outsourcing facility formulation agreements.
Leads expert panel review of RFPs received and selection of candidates for formulation agreements.
Conducts site visits to outsourcing facilities as related to grant project.
Works with Grants Manager and PI to complete all grant reporting requirements, including financial reports, annual or periodic status reports, and audits.
Works with PI to prepare and submit manuscripts, abstracts, and / or conference presentations
Supports activities related to identifying and applying for new, related funding opportunities.
Sets policies and procedures to achieve desired outcomes/results for their assigned work area(s).
Collaborates with external stakeholders related to drug supply chains, medication shortages, compounding, and outsourcing facilities.
Provides guidance to ASHP members, staff and external stakeholder organizations regarding evidence-based pharmacy practices, including pharmacy operations and pharmacy management.
Reviews, analyzes and advises staff, members and external stakeholder organizations on the implications of proposed guidelines, standards, quality measures and other initiatives by various organizations that impact pharmacy operations, pharmaceutical supply chains, quality and patient safety.
Performs other duties as assigned.